Bioventix (LON:BVXP) Stock Price Passes Above 50-Day Moving Average – What’s Next?

Bioventix PLC (LON:BVXP – Get Free Report) passed above its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of GBX 1,691.85 and traded as high as GBX 1,700. Bioventix shares last traded at GBX 1,600, with a volume of 8,422 shares traded.

Bioventix Price Performance

The firm has a market cap of £81.51 million, a PE ratio of 11.10 and a beta of 0.56. The business has a fifty day moving average price of GBX 1,691.85 and a two-hundred day moving average price of GBX 1,714.30.

Get Bioventix alerts:

Bioventix (LON:BVXP – Get Free Report) last issued its quarterly earnings results on Monday, March 30th. The biotechnology company reported GBX 69.38 earnings per share for the quarter. Bioventix had a return on equity of 65.83% and a net margin of 59.30%.The business had revenue of GBX 615.88 billion for the quarter. As a group, sell-side analysts forecast that Bioventix PLC will post 166.3066955 EPS for the current fiscal year.

Insider Activity

In other Bioventix news, insider Peter John Harrison purchased 1,065 shares of the stock in a transaction dated Wednesday, April 8th. The shares were acquired at an average price of GBX 1,849 per share, for a total transaction of £19,691.85. Also, insider Ian James Nicholson purchased 1,000 shares of the stock in a transaction dated Friday, April 10th. The shares were acquired at an average price of GBX 1,848 per share, for a total transaction of £18,480. Over the last quarter, insiders have acquired 2,131 shares of company stock worth $3,927,999. 6.22% of the stock is owned by corporate insiders.

About Bioventix

(Get Free Report)

Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; and Pyrene (HOP-G) ELISA kit to monitor human exposure to industrial pollutants. It also provides contract SMAs and recombinant services. Bioventix PLC was incorporated in 2003 and is based in Farnham, United Kingdom.

Further Reading

• Five stocks we like better than Bioventix
• The Bank of Mom and Dad Is Booming—3 Stocks to Watch
• Corning Is Paving AI’s Future With Glass
• Why’s Amazon Suddenly Lagging the S&P 500, and Is It a Warning?
• Crypto Winter Is Here: 3 Stocks To Put On Ice This Summer

Receive News & Ratings for Bioventix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioventix and related companies with MarketBeat.com's FREE daily email newsletter.